Organigram Global Inc. (TSX:OGI)
0.9000
-0.0600 (-6.25%)
Nov 19, 2026, 4:00 PM EST
Organigram Global Market Cap
Organigram Global has a market cap or net worth of CAD 126.91 million as of November 19, 2026. It is the 25,216th most valuable company in the world and the 641st biggest in Canada. Its market cap has decreased by 56.66% in one year.
Market Cap
126.91M
Enterprise Value
217.95M
Revenue
309.18M
Global Rank
Country Rank
#641 Canada
PE Ratio
1.42
ChartMarket Cap Chart
Since August 26, 2014, Organigram Global's market cap has increased from 103.20M to 126.91M, an increase of 22.97%. That is a compound annual growth rate of 1.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 126.91M | -59.31% |
| Dec 31, 2025 | 311.86M | 7.48% |
| Dec 31, 2024 | 290.16M | 107.85% |
| Dec 29, 2023 | 139.60M | -59.57% |
| Dec 30, 2022 | 345.24M | -49.95% |
| Dec 31, 2021 | 689.84M | 75.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cresco Labs | 263.38M |
| BioSyent | 201.64M |
| Cannara Biotech | 199.41M |
| Medexus Pharmaceuticals | 179.02M |
| TerrAscend | 173.00M |
| Cardiol Therapeutics | 162.38M |
| Grown Rogue International | 127.47M |
| HLS Therapeutics | 114.16M |